PURETECH HEALTH PLC ORDINARY SHARES UNI (OTCMKTS:PTCHF) Shorted Shares Reduced By 85.37%

PureTech Health plc (OTCMKTS:PTCHF) Corporate Logo

PURETECH HEALTH PLC ORDINARY SHARES UNI (OTCMKTS:PTCHF) had a decrease of its short interest by 85.37%. FINRA announced short interest of PTCHF’s total 600 shares. Previously was reported down change of 85.37% from 4,100 shares. 0 days will cost PTCHF with 11,600 average volume to restore its previous position.

Lastly it traded at $2.2.It’s since December 6, 2017 and is 0.00% down. The stock underperformed the S&P 500 by 15.62%.

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems.The firm is worth $641.11 million. The firm is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.8.53 is the P/E ratio. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.